Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
Fiche publication
Date publication
mai 2017
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Cholapranee A, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN
Lien Pubmed
Résumé
Mucosal healing is an important therapeutic endpoint in the management of Crohn's disease (CD) and ulcerative colitis (UC). Limited data exist regarding the comparative efficacy of various therapies in achieving this outcome.
Mots clés
Antibodies, Monoclonal, therapeutic use, Biological Factors, therapeutic use, Biological Products, therapeutic use, Colitis, Ulcerative, drug therapy, Crohn Disease, drug therapy, Humans, Immunosuppressive Agents, therapeutic use, Induction Chemotherapy, Maintenance Chemotherapy, Mucous Membrane, drug effects, Randomized Controlled Trials as Topic, Treatment Outcome, Wound Healing, drug effects
Référence
Aliment. Pharmacol. Ther.. 2017 May;45(10):1291-1302